Johnson & Johnson announced plans to spin off its DePuy Synthes Orthopaedics business to enhance focus and growth, creating a standalone orthopaedics company expected to be the largest in its field, with a strategic move aimed at boosting margins and market share, led by newly appointed president Namal Nawana.
Sean "Diddy" Combs' business empire continues to decline as he sells his shares in Revolt, steps down from his chairman role, and faces multiple accusations of abuse. Revolt, now employee-owned, distances itself from Combs, who has also sold his stake in the tequila brand DeLeón and lost a Hulu reality show.
BlackBerry has appointed John J. Giamatteo as its new CEO and announced the full separation of its IoT and Cybersecurity business units, which will operate as standalone divisions. The company will no longer pursue an IPO for its IoT business. The restructuring process will involve streamlining centralized functions and right-sizing cost structures. The move is aimed at enhancing shareholder value and providing greater options for the company's future.
Johnson & Johnson's consumer-health unit Kenvue soared more than 22% on its first day of trading, bringing the company one step closer to completing its business separation. The planned split, set for later this year, is in the best interest of shareholders of both the soon-to-be-solo Kenvue operations and the new pharma and medtech-focused J&J.